NORTHERN CLINICS OF ISTANBUL, cilt.7, sa.2, ss.118-123, 2020 (ESCI)
OBJECTIVE: Juvenile idiopathic arthritis (JIA) is the most common cause of chronic arthritis in children. Biologics have changed the faith of children with rheumatic diseases. The main objective of this study was to demonstrate the rate of usage, efficacy and safety of biologics in JIA subtypes.